Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Non-Current Assets (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Non-Current Assets for 2 consecutive years, with $19.4 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 21.53% to $19.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $89.2 million through Dec 2025, down 46.39% year-over-year, with the annual reading at $19.4 million for FY2025, 21.53% down from the prior year.
  • Non-Current Assets for Q4 2025 was $19.4 million at Pyxis Oncology, down from $22.5 million in the prior quarter.
  • The five-year high for Non-Current Assets was $47.8 million in Q1 2024, with the low at $19.4 million in Q4 2025.